Page last updated: 2024-09-04

rhodioloside and Brain Disorders

rhodioloside has been researched along with Brain Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Gai, Y; Huang, J; Li, L; Luan, Y; Pan, J; Xiao, L; Xu, Z1
Fu, C; Huang, Y; Liu, WQ; Liu, XZ; Lv, P; Meng, L; Wang, XB; Wang, XH; Wang, YF; Yang, Q; Zhao, LP; Zheng, DY; Zuo, ZF1

Other Studies

2 other study(ies) available for rhodioloside and Brain Disorders

ArticleYear
Salidroside attenuates lipopolysaccharide-induced neuroinflammation and cognitive impairment in septic encephalopathy mice.
    International immunopharmacology, 2023, Volume: 117

    Topics: Animals; Anti-Inflammatory Agents; Brain Diseases; Cognitive Dysfunction; Cytokines; Lipopolysaccharides; Mice; Neuroinflammatory Diseases; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Sirtuin 1

2023
Neuroprotective effect of salidroside on hippocampal neurons in diabetic mice via PI3K/Akt/GSK-3β signaling pathway.
    Psychopharmacology, 2023, Volume: 240, Issue:9

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain Diseases; Caspase 3; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypoglycemia; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction

2023